Laboratory Medicine
Test Directory / Haptoglobin
Haptoglobin
Brown clotted serum, gel barrier or lithium heparin
| Test | Haptoglobin |
|---|---|
| Common Abbreviations | HP, HAPT |
| Profile | NA |
| Tube type | Brown clotted serum, gel barrier or lithium heparin |
| Clinical Indication | Haptoglobin is used primarily to screen for and to follow the course of haemolytic disorders. Plasma levels are increased in the presence of acute inflammatory processes, tissue necrosis, malignancy, protein losing syndromes (e.g. nephrotic syndrome or protein losing enteropathies) and in corticosteroid therapy. Plasma levels are decreased in haemolytic disease and ineffective erythropoiesis, genetic deficiency, due to endogenous or exogenous oestrogens and in hepatocellular diseases. |
| Specimen Type | Blood |
| Sample type | Serum |
| Minimum Volume | 0.5mL If requesting more than 10 tests please send an additional brown clotted serum sample. |
| Special Precautions | No special requirements |
| Stability | 3 months at 15-25°C and 8 Months at 2-8°C |
| Turnaround Time | Inpatient: 4 days Outpatient/ GP: 4 days |
| Laboratory | Scarborough |
| Reference Interval | Adults: 0.3-2.0 g/L (Quoted by the manufacturer) |
| Limitations | Grossly lipaemic or haemolysed samples are not suitable for analysis. Samples with extremely abnormal optical characteristics, especially turbidity may produce atypical results. |
| Notes |
